Bortlik Martin, Vitkova Ivana, Papezova Martina, Kohoutova Milada, Novotny Ales, Adamec Stanislav, Chalupna Petra, Lukas Milan
Gastroenterology Center, 4th Internal Department, General Faculty Hospital, 1st School of Medicine, Charles University, Prague, Czech Republic.
World J Gastroenterol. 2006 Jun 28;12(24):3901-5. doi: 10.3748/wjg.v12.i24.3901.
To evaluate the frequency of the loss of the Adenomatous Polyposis Coli (APC) protein and to compare the APC status with the characteristics of colorectal adenomas.
Immunohistochemical analysis of the APC protein was performed on 118 adenomas and the results were compared with parameters of malignant potential, location of adenomas, macroscopic appearance and age of the patients.
A complete loss of the APC protein was found in 28 (24%) adenomas, while 90 (76%) were APC positive. The mean size of adenomas was 13.5 +/- 14.2 mm (95% CI 10.5-16.5) in APC-positive, and 13.8 +/- 15.5 mm (95% CI 7.8-19.8) in APC-negative adenomas (P = 0.364). Statistical analysis revealed no difference between APC-positive and negative adenomas as to the histological type (P = 0.327) and grade of dysplasia (P = 0.494). We found that even advanced adenomas did not differ in their APC status from the non-advanced tumors (P = 0.414). Finally, no difference was found when the location (P = 0.157), macroscopic appearance (P = 0.571) and age of patients (P = 0.438) were analysed and compared between both APC positive and negative adenomas.
Most adenomas expressed full-length APC protein, suggesting that protein expression is not a reliable marker for assessment of APC gene mutation. Complete loss of APC protein did not influence morphology, location, or appearance of adenomas, nor was it affected by the patient's age.
评估腺瘤性息肉病 coli(APC)蛋白缺失的频率,并将 APC 状态与结直肠腺瘤的特征进行比较。
对 118 例腺瘤进行 APC 蛋白的免疫组化分析,并将结果与恶性潜能参数、腺瘤位置、大体外观及患者年龄进行比较。
28 例(24%)腺瘤中发现 APC 蛋白完全缺失,而 90 例(76%)为 APC 阳性。APC 阳性腺瘤的平均大小为 13.5±14.2 毫米(95%置信区间 10.5 - 16.5),APC 阴性腺瘤为 13.8±15.5 毫米(95%置信区间 7.8 - 19.8)(P = 0.364)。统计分析显示,APC 阳性和阴性腺瘤在组织学类型(P = 0.327)和发育异常分级(P = 0.494)方面无差异。我们发现,即使是进展期腺瘤,其 APC 状态与非进展期肿瘤也无差异(P = 0.414)。最后,在分析和比较 APC 阳性和阴性腺瘤的位置(P = 0.157)、大体外观(P = 0.571)及患者年龄(P = 0.438)时,未发现差异。
大多数腺瘤表达全长 APC 蛋白,提示蛋白表达不是评估 APC 基因突变的可靠标志物。APC 蛋白的完全缺失不影响腺瘤的形态、位置或外观,也不受患者年龄的影响。